Data / Drug companies / Glyburide
Glyburide: 17 companies and 54 products in the FDA NDC directory
Glyburide is listed in the FDA National Drug Code Directory by 17 companies, with 54 products in commercial distribution. 51 of the products (94.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on January 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 54
- Generic (ANDA) products
- 51 (94.4%)
- Application numbers
- 6
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list glyburide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | tablet | Generic drugs (ANDA) | May 12, 1999 |
| NuCare Pharmaceuticals,Inc. | 7 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| A-S Medication Solutions | 6 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| Cadila Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | April 26, 2014 |
| Chartwell RX, LLC | 3 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Modavar Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | October 5, 2021 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | June 2, 2016 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | June 2, 2016 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | March 23, 2021 |
| Preferred Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | January 27, 2026 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | March 11, 2024 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | December 8, 2025 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | October 5, 2010 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | August 30, 1995 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 54 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 51 | 94.4% |
| Authorized generics (NDA) | 3 | 5.6% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sulfonylurea | 54 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.